Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists

Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists

US Patent 7329673 · Granted Feb 12, 2008

Estimated economic value: $61,671,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Electronic devices with dual track dynamic voltage and frequency management2025
Inhibitors of histone deacetylase useful for the treatment or prevention of HIV 2025
2-amino-n-phenyl-nicotinamides as NAV1.8 inhibitors2025
Inhibitors of histone deacetylase useful for the treatment or prevention of HIV 2025
Factor XI activation inhibitors2025
Inhibitors of histone deacetylase-3 useful for the treatment of cancer, inflamma2025
NK3 modulators and uses thereof2025
Dual-drug co-delivery system, preparation method therefor and use thereof2025
Substituted piperazine amide compounds as indoleamine 2,3-dioxygenase (IDO) inhi2025
Substituted piperazine amide compounds as indoleamine 2,3-dioxygenase (IDO) inhi2025
GPR40 agonists2025
GPR40 agonists2025